<DOC>
<DOCNO>
EP-0000891
</DOCNO>
<TEXT>
<DATE>
19790307
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-31/43</main> A61P-31/00 A61K-31/43 A61K-31/429 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
synergistic combinations of penicillins and antibiotic agents containing them.
</TITLE>
<APPLICANT>
bayer agde<sep>bayer aktiengesellschaft<sep>bayer ag51368 leverkusende<sep>bayer aktiengesellschaft  <sep>
</APPLICANT>
<INVENTOR>
metzger karl georg dr<sep>metzger, karl georg, dr.<sep>metzger, karl georg, dr.pahlkestrasse 15d-5600 wuppertal 1de<sep>metzger, karl georg, dr.<sep>metzger, karl georg, dr.pahlkestrasse 15d-5600 wuppertal 1de<sep>
</INVENTOR>
<ABSTRACT>
Drug combinations from known penicillins containing at least one active ingredient from the group D-α - [(imidazolidine-2-one-1-yl) -carbonylamino] -benzylpenicillin and D-α - [(3-methylsulfonyl-imidazolidine-2-one-1-YL) -Carbonylamino] -benzylpenicillin and at least one active ingredient from the group 3- (2,6-dichlorophenyl) -5-methyl-4-is-oxazolylpenicillin, 3- (2-chloro-6-fluorophenyl) -5-Methyl-4-IS Oxazolylpenicillin, 3- (2-chlorophenyl) -5-methyl-4-isoxazolylpenicillin, 3-phenyl-5-methyl-4-isoxazolylpenicillin and 2,6-dimethoxyphenylpenicillin have synergistic effects as they are against bacteriaThe genus of β-lactamase forming adhesives are effective.
</ABSTRACT>
</TEXT>
</DOC>
